S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3)

Detalles Bibliográficos
Autores principales: Dimopoulos, Meletios A., Hungria, Vania, Radinoff, Atanas, Delimpasi, Sosana, Mikala, Gabor, Masszi, Tamas, LI, Jian, Capra, Marcelo Eduardo, Matsumoto, Morio, Sule, Neal, LI, Mary, Mckeown, Astrid, He, Wei, Bright, Shelley, Currie, Brooke, Boyle, Julia, Opalinska, Joanna, Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428262/
http://dx.doi.org/10.1097/01.HS9.0000967708.07200.5a
Descripción
Sumario:

Ejemplares similares